Target
Mouse CTLA4 / CD152
Synonyms
CTLA4 | CD152 | CELIAC3 | CD152 antigen | CTLA-4 | Celiac disease 3 | IDDM12 | GRD4 | GSE | CD152 isoform
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Immunogen
Extracellular portion of mouse CD152 fused to a mouse IgG2a.
Specificity
Recognizes mouse CD152, commonly known as CTLA-4 (cytotoxic T-lymphocyte protein 4), a structural homolog for CD28. CD152 binds the same ligands as CD28, namely CD80 (B7.1) and CD86 (B7.2), but with much higher affinity. However, while binding of CD28 enhances T cell function, binding of CD152 inhibits it. CD152 is not detected on naive T-cells and is induced upon T-cell activation. In mice, lack of CD152 leads to massive lymphoproliferative disorder leading to tissue destruction and autoimmunity, suggesting a critical role for CD152 in limiting T-cell responses. CD152 has been shown to reduce IL-2 production after ligation and can inhibit T-cell expansion. This regulatory role and the high binding affinity of CD152 make it a potential therapy for autoimmune diseases such as rheumatoid arthritis. Clone 1B8 may be used to enhance proliferation and pro-inflammatory cytokines of lymph node cells. It may also be used to enhance tumor immunity.